Iron oxide nanoparticle targeted chemo-immunotherapy for triple negative breast cancer.

Mu, Qin Gxin; Lin, Guanyou; Jeon, Mike; Wang, Hui; Chang, Fei-Chien; Revia, Richard A; Yu, John; Zhang, Miqin

Mu, Qin Gxin; Lin, Guanyou; Jeon, Mike; Wang, Hui; Chang, Fei-Chien; Revia, Richard A; Yu, John; Zhang, Miqin.

Afiliação

Mu QG; Department of Materials Science and Engineering, University of Washington, Seattle, WA 98195, USA.
Lin G; Department of Materials Science and Engineering, University of Washington, Seattle, WA 98195, USA.
Jeon M; Department of Materials Science and Engineering, University of Washington, Seattle, WA 98195, USA.
Wang H; Department of Materials Science and Engineering, University of Washington, Seattle, WA 98195, USA.
Chang FC; Department of Materials Science and Engineering, University of Washington, Seattle, WA 98195, USA.
Revia RA; Department of Materials Science and Engineering, University of Washington, Seattle, WA 98195, USA.
Yu J; Department of Neurosurgery, Maxine-Dunitz Neurosurgical Institute, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA.
Zhang M; Department of Materials Science and Engineering, University of Washington, Seattle, WA 98195, USA.

Mater Today (Kidlington) ; 50: 149-169, 2021 Nov.

Article em En | MEDLINE | ID: mdl-34987308

Palavras-chave

Iron oxide nanoparticles; doxorubicin; endoglin binding peptide; immunotherapy; metastasis; triple negative breast cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Mater Today (Kidlington) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google